Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simrit Parmar

Showing results (91-100 of 119) with videos related to

Pageof 12
Sort By:
Haematologica|August 8, 2015
Better allele-level matching improves transplant-related mortality after double cord blood transplantationBetül Oran, Kai Cao, Rima M Saliba, et al.
Leukemia & Lymphoma|July 11, 2019
Misidentification of <i>MLL3</i> and other mutations in cancer due to highly homologous genomic regionsTimothy G Bowler, Kith Pradhan, Yu Kong, et al.
Cytotherapy|October 8, 2013
Fucosylation with fucosyltransferase VI or fucosyltransferase VII improves cord blood engraftmentSimon N Robinson, Michael W Thomas, Paul J Simmons, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 23, 2013
A randomized phase II trial of fludarabine/melphalan 100 versus fludarabine/melphalan 140 followed by allogeneic hematopoietic stem cell transplantation for patients with multiple myelomaQaiser Bashir, Hassan Khan, Peter F Thall, et al.
British Journal of Haematology|March 16, 2017
Phase I study of cord blood-derived natural killer cells combined with autologous stem cell transplantation in multiple myelomaNina Shah, Li Li, Jessica McCarty, et al.
Transplantation and Cellular Therapy|May 9, 2021
Eltrombopag for Post-Transplantation Thrombocytopenia: Results of Phase II Randomized, Double-Blind, Placebo-Controlled TrialSairah Ahmed, Qaiser Bashir, Roland Bassett, et al.
Bone Marrow Transplantation|May 24, 2022
A randomized phase III study of pretransplant conditioning for AML/MDS with fludarabine and once daily IV busulfan ± clofarabine in allogeneic stem cell transplantationBorje S Andersson, Peter F Thall, Junsheng Ma, et al.
Blood|July 24, 2014
Regulatory B cells are enriched within the IgM memory and transitional subsets in healthy donors but are deficient in chronic GVHDAhmad Khoder, Anushruti Sarvaria, Abdullah Alsuliman, et al.
Journal of Cancer|May 4, 2018
International Consensus on the Clinical Management of Inflammatory Breast Cancer from the Morgan Welch Inflammatory Breast Cancer Research Program 10th Anniversary ConferenceNaoto T Ueno, Jose Rodrigo Espinosa Fernandez, Massimo Cristofanilli, et al.
Acta Haematologica|July 1, 2020
Cytogenetics and Blast Count Determine Transplant Outcomes in Patients with Active Acute Myeloid LeukemiaAmanda L Olson, Rima M Saliba, Betul Oran, et al.
Pageof 12

Showing results (91-100 of 119) with videos related to

Sort By:
Pageof 12
Haematologica|August 8, 2015
Better allele-level matching improves transplant-related mortality after double cord blood transplantationBetül Oran, Kai Cao, Rima M Saliba, et al.
Leukemia & Lymphoma|July 11, 2019
Misidentification of <i>MLL3</i> and other mutations in cancer due to highly homologous genomic regionsTimothy G Bowler, Kith Pradhan, Yu Kong, et al.
Cytotherapy|October 8, 2013
Fucosylation with fucosyltransferase VI or fucosyltransferase VII improves cord blood engraftmentSimon N Robinson, Michael W Thomas, Paul J Simmons, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 23, 2013
A randomized phase II trial of fludarabine/melphalan 100 versus fludarabine/melphalan 140 followed by allogeneic hematopoietic stem cell transplantation for patients with multiple myelomaQaiser Bashir, Hassan Khan, Peter F Thall, et al.
British Journal of Haematology|March 16, 2017
Phase I study of cord blood-derived natural killer cells combined with autologous stem cell transplantation in multiple myelomaNina Shah, Li Li, Jessica McCarty, et al.
Transplantation and Cellular Therapy|May 9, 2021
Eltrombopag for Post-Transplantation Thrombocytopenia: Results of Phase II Randomized, Double-Blind, Placebo-Controlled TrialSairah Ahmed, Qaiser Bashir, Roland Bassett, et al.
Bone Marrow Transplantation|May 24, 2022
A randomized phase III study of pretransplant conditioning for AML/MDS with fludarabine and once daily IV busulfan ± clofarabine in allogeneic stem cell transplantationBorje S Andersson, Peter F Thall, Junsheng Ma, et al.
Blood|July 24, 2014
Regulatory B cells are enriched within the IgM memory and transitional subsets in healthy donors but are deficient in chronic GVHDAhmad Khoder, Anushruti Sarvaria, Abdullah Alsuliman, et al.
Journal of Cancer|May 4, 2018
International Consensus on the Clinical Management of Inflammatory Breast Cancer from the Morgan Welch Inflammatory Breast Cancer Research Program 10th Anniversary ConferenceNaoto T Ueno, Jose Rodrigo Espinosa Fernandez, Massimo Cristofanilli, et al.
Acta Haematologica|July 1, 2020
Cytogenetics and Blast Count Determine Transplant Outcomes in Patients with Active Acute Myeloid LeukemiaAmanda L Olson, Rima M Saliba, Betul Oran, et al.
Pageof 12